The chemical substance known as "1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-, (2R,3aS,5aR,5bS)" with CAS number 131929-65-2 is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups and stereocenters. This substance features a bicyclic core structure, indicative of its potential biological activity, and is likely to exhibit properties such as solubility in organic solvents, potential reactivity due to the presence of carbonyl groups, and the ability to form hydrogen bonds due to hydroxyl functionalities. The presence of a sugar moiety suggests that it may interact with biological systems, possibly influencing its pharmacological properties. Its stereochemistry, denoted by specific configurations at various chiral centers, may also play a crucial role in determining its biological interactions and overall efficacy in applications such as drug development or biochemical research.

1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-, (2R,3aS,5aR,5bS,

131929-65-2: The chemical substance known as "1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-, (2R,3aS,5aR,5bS)" with CAS number 131929-65-2 is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups and stereocenters. This substance features a bicyclic core structure, indicative of its potential biological activity, and is likely to exhibit properties such as solubility in organic solvents, potential reactivity due to the presence of carbonyl groups, and the ability to form hydrogen bonds due to hydroxyl functionalities. The presence of a sugar moiety suggests that it may interact with biological systems, possibly influencing its pharmacological properties. Its stereochemistry, denoted by specific configurations at various chiral centers, may also play a crucial role in determining its biological interactions and overall efficacy in applications such as drug development or biochemical research.

CAS 131929-65-2

1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-, (2R,3aS,5aR,5bS,

Spinosyn F

Ref: ST-EA-CP-S112011